Daily Briefing: September 30, 2026

Executive Summary

Today's briefing highlights major shifts across artificial intelligence and market dynamics. OpenAI takes center stage with a massive valuation milestone for pharmaceutical AI and the launch of the cost-efficient GPT-6.1 Sol model. Meanwhile, founders must recalibrate their go-to-market strategies around a newly revealed thirty-day monetization window, while traditional sectors face structural upheaval.

Share today's executive briefing

Keep your team and co-founders in the loop.